The Manufacturers Who Can Least Afford Downtime Are the Ones Most Likely to Cause It

There is a pattern I have watched repeat itself across 25 years of this industry, and it bothers me enough to write about it.

A tissue manufacturer is setting up their operation. Margins are tight — they know this going in. So they do what most Indian businesses do when margins are tight: they cut the upfront cost. They buy the cheapest machine they can find, tell themselves quality will come later, and start production.

Six months in, the machine goes down. The repair bill arrives. The production day is lost. And the manufacturer who bought cheap to protect their margin has now spent that margin — and then some — on a breakdown they could not afford.

I am in the business of selling machines, so I understand the conflict in writing this. Take it for what it is: an observation from someone who has watched this happen more times than I can count.

We have a cultural problem in India when it comes to market entry. The default belief is that you must enter cheap — low price first, quality later. The assumption is that buyers won't pay for quality until you've proven yourself, so prove yourself with price.

This logic works in some industries. It does not work in manufacturing equipment.

A tissue machine is not a product you trial and upgrade. It is a capital investment you live with for 15 to 20 years. The decision you make on day one follows your business for two decades. There is no "quality later." There is only what you bought.

The deeper problem is that we have confused selling cheap with making cheap. These are not the same thing. Selling cheap is a market strategy — price your product aggressively to win share, then build value over time. Making cheap is a manufacturing failure — cut component quality to hit a price point, and deliver a machine that reflects exactly what was paid for it.

Indian tissue machine manufacturers who compete on price are not selling cheap. They are making cheap. The buyer is not getting a discount on a quality machine. They are getting a machine built to the price they negotiated.

Which brings me to the paradox that bothers me most.

The tissue manufacturers operating on the thinnest margins are the ones who most need their machines to run every single day. One day of downtime does not just cost a repair bill — it costs the profit that day was supposed to generate. Two hits, simultaneously, on a business that cannot absorb either one.

And yet these are precisely the manufacturers most likely to buy the machine with the highest probability of causing that downtime.

I am not arguing that everyone should buy the most expensive machine available. I am arguing that the calculation most buyers run — upfront cost only — is incomplete. A machine that costs more on day one and runs for 20 years without failure is not expensive. A machine that costs less on day one and fails four times a year is not cheap.

The manufacturers who figure this out first will outlast the ones who don't. That is not a sales pitch. It is arithmetic.

Aahan Birla is Director of Exports, Product Development & Marketing at Birla Hi-Tech Machines — a third-generation tissue paper conversion machine manufacturer based in Faridabad, Haryana. The company has delivered over 1,200 machines across 22 countries in 25 years of operation, backed by a family manufacturing legacy tracing to 1977.

/ FEATURED PRODUCT

Interested in the machines behind this industry?

Birla Hi-Tech Machines manufactures tissue converting equipment used by businesses across 22 countries.

Share this article